PRPO – Precipio Inc
Precipio, Inc.PRPO
$20.83Name : Precipio, Inc.
Sector : Healthcare
Industry: Diagnostics & Research
Mark. Cap: $33,735,936.00
EPSttm : -1.19
Precipio, Inc.
$20.83
7.76%$1.50Float Short %
0.1
Margin Of Safety %
-24
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
19.22
Target Price
19
Analyst Recom
1
Performance Q
31.5
Relative Volume
1.08
Beta
1.11
Ticker: PRPO
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-10-20 | PRPO | 18.41 | N/A | N/A | 0 |
| 2025-10-21 | PRPO | 21.67 | N/A | N/A | 0 |
| 2025-10-22 | PRPO | 21.37 | N/A | N/A | 0 |
| 2025-10-23 | PRPO | 21.92 | N/A | N/A | 0 |
| 2025-10-24 | PRPO | 20.55 | N/A | N/A | 0 |
| 2025-10-27 | PRPO | 21.55 | N/A | N/A | 0 |
| 2025-10-28 | PRPO | 21.26 | N/A | N/A | 0 |
| 2025-10-29 | PRPO | 20.58 | N/A | N/A | 0 |
| 2025-10-30 | PRPO | 20.47 | N/A | N/A | 0 |
| 2025-10-31 | PRPO | 20.84 | N/A | N/A | 0 |
| 2025-11-03 | PRPO | 20.05 | N/A | N/A | 0 |
| 2025-11-04 | PRPO | 20.02 | N/A | N/A | 0 |
| 2025-11-05 | PRPO | 20.08 | N/A | N/A | 0 |
| 2025-11-06 | PRPO | 20 | N/A | N/A | 0 |
| 2025-11-07 | PRPO | 19.9 | N/A | N/A | 0 |
| 2025-11-10 | PRPO | 20.04 | N/A | N/A | 0 |
| 2025-11-11 | PRPO | 20.19 | N/A | N/A | 0 |
| 2025-11-12 | PRPO | 20.15 | N/A | N/A | 0 |
| 2025-11-13 | PRPO | 19.52 | N/A | N/A | 0 |
| 2025-11-14 | PRPO | 18.98 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-10-20 | PRPO | 18.24 | - | - | - |
| 2025-10-21 | PRPO | 21.71 | - | - | - |
| 2025-10-22 | PRPO | 21.07 | - | - | - |
| 2025-10-23 | PRPO | 21.99 | - | - | - |
| 2025-10-24 | PRPO | 20.61 | - | - | - |
| 2025-10-27 | PRPO | 21.25 | - | - | - |
| 2025-10-28 | PRPO | 21.00 | - | - | - |
| 2025-10-29 | PRPO | 21.25 | - | - | - |
| 2025-10-30 | PRPO | 20.47 | - | - | - |
| 2025-10-31 | PRPO | 20.50 | - | - | - |
| 2025-11-03 | PRPO | 20.12 | - | - | - |
| 2025-11-04 | PRPO | 19.85 | - | - | - |
| 2025-11-05 | PRPO | 20.46 | - | - | - |
| 2025-11-06 | PRPO | 20.28 | - | - | - |
| 2025-11-07 | PRPO | 20.00 | - | - | - |
| 2025-11-10 | PRPO | 20.24 | - | - | - |
| 2025-11-11 | PRPO | 20.19 | - | - | - |
| 2025-11-12 | PRPO | 20.68 | - | - | - |
| 2025-11-13 | PRPO | 19.94 | - | - | - |
| 2025-11-14 | PRPO | 19.22 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-10-20 | PRPO | 3.76 | -2.39 | 0.10 |
| 2025-10-21 | PRPO | 3.76 | -2.39 | 0.10 |
| 2025-10-22 | PRPO | 3.72 | -2.39 | 0.10 |
| 2025-10-23 | PRPO | 3.72 | -2.39 | 0.10 |
| 2025-10-24 | PRPO | 3.72 | -2.39 | 0.10 |
| 2025-10-27 | PRPO | 3.72 | -2.35 | 0.03 |
| 2025-10-28 | PRPO | 3.72 | -2.35 | 0.03 |
| 2025-10-29 | PRPO | 3.72 | -2.35 | 0.03 |
| 2025-10-30 | PRPO | 3.72 | -2.35 | 0.03 |
| 2025-10-31 | PRPO | 3.72 | -2.35 | 0.03 |
| 2025-11-03 | PRPO | 3.72 | -2.44 | 0.03 |
| 2025-11-04 | PRPO | 3.72 | -2.44 | 0.03 |
| 2025-11-05 | PRPO | 3.71 | -2.44 | 0.03 |
| 2025-11-06 | PRPO | 3.71 | -2.44 | 0.03 |
| 2025-11-07 | PRPO | 3.71 | -2.44 | 0.03 |
| 2025-11-10 | PRPO | 3.71 | -2.40 | 0.03 |
| 2025-11-11 | PRPO | 3.71 | -2.40 | 0.03 |
| 2025-11-12 | PRPO | 3.71 | -2.40 | 0.10 |
| 2025-11-13 | PRPO | 3.71 | -2.40 | 0.10 |
| 2025-11-14 | PRPO | 3.71 | -2.40 | 0.10 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
3.71
Institutional Transactions
-2.4
Beta
1.11
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
14.53
Quality Score
44
Growth Score
54
Sentiment Score
80
Actual DrawDown %
89.5
Max Drawdown 5-Year %
-95.8
Target Price
19
P/E
Forward P/E
PEG
P/S
1.47
P/B
2.39
P/Free Cash Flow
55.9
EPS
-1.21
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-8.48
Relative Volume
1.08
Return on Equity vs Sector %
-41.5
Return on Equity vs Industry %
-25.6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Precipio, Inc.Sector: Healthcare
Industry: Diagnostics & Research
Employees: 54
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
stock quote shares PRPO – Precipio Inc Stock Price stock today
news today PRPO – Precipio Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch PRPO – Precipio Inc yahoo finance google finance
stock history PRPO – Precipio Inc invest stock market
stock prices PRPO premarket after hours
ticker PRPO fair value insiders trading